Pituitary adenylate cyclase-activating polypeptide protects rat-cultured cortical neurons from glutamate-induced cytotoxicity

Brain Research

Volumn 741, Issue 1-2, 1996, Pages 82-88

  Morio, Hiroshi ^a   Tatsuno, Ichiro ^a   Hirai, Aizan ^a   Tamura, Yasushi ^b   Saito, Yasushi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Hiratsuka City Hospital   (Japan)

Author keywords

cortical neuron; cyclic AMP; cytoprotection; glutamate; neurotoxicity; PACAP

Indexed keywords

BUCLADESINE; CYCLIC AMP; GLUTAMIC ACID; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CELL CULTURE; CONTROLLED STUDY; FETUS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARGININE VASOPRESSIN; BUCLADESINE; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CYCLIC AMP; GLUTAMIC ACID; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; NEURONS; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 0030602003     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00920-1     Document Type: Article

References (47)

1. [1] Arimura, A., Somogyvari-Vigh, A., Weill, C., Fiore, R.C., Tatsuno, I., Bay, V. and Brenneman, D.E., PACAP functions as a neurotrophic factor, Ann. NY Acad. Sci., 739 (1994) 228-243.
2. [2] Arimura, A., Pituitary adenylate cyclase activating polypeptide (PACAP)-discovery and current status of research, Regul. Peptides, 37 (1992) 287-303.
3. [3] Arimura, A., Somogyvari-Vigh, A., Miyata, A., Mizuno, K., Coy, D.H. and Kitada, C., Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes, Endocrinology, 129 (1991) 2787-2789.
4. [4] Basille, M., Gonzalez, B.J., Leroux, P., Jeandel, L., Fournier, A. and Vaudry, H., Localization and characterization of PACAP receptors in the rat cerebellum during development-evidence for a stimulatory effect of PACAP on immature cerebellar granule cells, Neuroscience, 57 (1993) 329-338.
5. [5] Baskin, D.G., Petracca, F. and Dorsa, D.M., Autoradiographic localization of specific binding sites for [3H][Arg8]vasopressin in the septum of the rat brain with tritium-sensitive film. Eur. J. Pharmacol., 90 (1983) 155-157.
6. [6] Brenneman, D.E., Fitzgerald, S. and Litzinger, M.J., Neuronal survival during electorical blockade is increased by 8-bromo cyclic adenosine 3′-5′monophosphate, J. Pharmacol. Exp. Ther., 233 (1985) 402-408.
7. [7] Brenneman, D.E., Neale, E.A., Foster, G.A., d'Autremont, S.W. and Westbrook, G.L., Nonneural cells mediate neurotrophic action of vasoactive intestinal peptide, J. Cell Biol., 104 (1987) 1603-1610.
8. [8] Brenneman, D.E., Westbrook, G.L., Fitzgerald, S.P., Ennist, D.L., Elkins, K.L., Ruff, M.R. and Pert, C.B., Neural cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptides, Nature, 335 (1988) 639-642.
9. [9] Brown, J. and Zuo, Z., C-type natriuretic peptide and atrial natriuretic peptide receptors of rat brain, Am. J. Physiol., 264 (1993) R513-R523.
10. [10] Cauvin, A., Robberecht, P., De Neef, P., Gouret, P., Vandermeers, A., Vandermeers-Piret, M.-C. and Christophe, J., Properties and distribution of receptor for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord, Regul. Peptides, 35 (1991) 161-173.
11. [11] Choi, D.W., Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemie damage, Trends Neurosci., 11 (1988) 465-469.
12. [12] Culler, M.D. and Paschall, C.S., Pituitary adenylate cyclase-activating polypeptide (PACAP) potentiates the gonadotropin-releasing activity of lutenizing hormone-releasing hormone, Endocrinology, 129 (1991) 2260-2262.
13. [13] Deutsch, P.J. and Sun, Y., The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PCl2 cells and promotes neurite outgrowth, J. Biol. Chem., 267 (1992) 5108-5113.
14. [14] DiCicco-Bloom, E.M. and Deutsch, P.J., Pituitary adenylate cyclase activating polypeptide (PACAP) potently stimulates mitosis, neurite genesis and survival in cultured rat sympathetic neuroblasts, Regul. Peptides, 37 (1992) 319.
15. [15] Ghatei, M.A., Takahashi, K., Suzuki, Y., Gardiner, J., Jones, P.M. and Bloom, S.R., Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues, J. Endocrinol., 136 (1993) 159-166.
16. [16] Goth, M.I., Lyons, C.E., Canny, B.J. and Thorner, M.O., Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors, Endocrinology, 130 (1992) 939-944.
17. [17] Gottschall, P.E., Tatsuno, I. and Arimura, A., Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification, FASEB J., 5 (1991) 194-199.
18. [18] Gottschall, P.E., Tatsuno, I. and Arimura, A., Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP), Brain Res., 637 (1994) 197-203.
19. +-induced degeneration, J. Neurosci. Res., 32 (1992) 190-201.
20. [20] Hernadez, F., Alexander, S.P.H. and Kendall, D.A., Natriuretic peptide-induced cyclic GMP accumulation in adult guinea-pig cerebellar slices, Br. J. Pharmacol., 113 (1994) 216-220.
21. [21] Hosli, E. and Hosli, L., Autoradiographic localization of binding sites for arginine vasopresssin and atrial natriuretic peptide on astrocytes and neurons of cultured rat central nervous system, Neuroscience, 51 (1992) 159-166.
22. [22] Kaiser, P.K. and Lipton, S.A., VIP-mediated increase in cAMP prevents tetrodotoxin-induced retinal ganglion cell death in vitro, Neuron, 5 (1990) 558-570.
23. [23] Mattson, M.P., Guthrie, P.B. and Kater, S.B., Intracellular messengers in the generation and degeneration of hippocampal neuroarchietecture, J. Neurosci. Res., 21 (1988) 447-464.
24. [24] Masuo, Y., Ohtaki, T., Masuda, Y., Nagai, Y., Suno, M., Tsuda, M. and Fujino, M., Autoradiographic distribution of pituitary adenylate cyclase activating polypeptide (PACAP) binding sites in the rat brain, Neurosci. Lett., 126 (1991) 103-106.
25. [25] Masuo, Y., Ohtaki, T., Masuda, Y., Tsuda, M. and Fujino, M., Binding sites for pituitary adenyloate cyclase activating polypeptide (PACAP)-comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain Sections, Brain Res., 575 (1992) 113-123.
26. [26] Minamino, N., Kangawa, K. and Matsuo, H., N-terminally extended form of C-type natriuretic peptide (CNP-53) identified in porcine brain, Biochem. Biophys. Res. Commun., 170 (1990) 973-979.
27. [27] Miyata, A., Arimura, A., Dahl, R.R., Minamino, N., Uehara, A., Jiang, L., Culler, M.D. and Coy, D.H., Isolation of novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells, Biochem. Biophys. Res. Commun., 164 (1989) 567-574.
28. [28] Miyata, A., Jiang, L., Dahl, R.R., Kitada, C., Kubo, K., Fujino, M., Minamino, N. and Arimura, A., Isolation of a neuropeptode corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38), Biochem. Biophys. Res. Commun., 170 (1990) 643-648.
29. [29] Osuga, Y., Mitsuhashi, N. and Mizuno, M., In vivo effect of pituitary adenylate cyclase activating polypeptide-38 (PACAP-38) on the secretion of luteinizing hormone (LH) in male rats, Endocrinol. Japon., 39 (1992) 153-156.
30. [30] Pincus, D.W., DiCicco-Bloom, E.M. and Black, I.E., Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sypathetic neuroblasts, Nature, 343 (1990) 564-567.
31. [31] Propatomussafiri, R., Kanse, S.M., Ghatei, M.A. and Bloom, S.R., Pituitary adenylate cyclase-activating polypeptide releases 7B2, adrenocorticotrophin, growth hormone and prolactin from the mouse and rat clonal pituitary cell lines AtT-20 and GH3, J. Endocrinol., 132 (1992) 107-113.
32. [32] Robberecht, P., Vertongen, P., Velkeniers, B., Deneef, P., Vergani, P., Raftopoulos, C., Brotchi, J., Hooghepeters, E.L. and Christophe, J., Receptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas, J. Clin. Endocrinol. Metab., 77 (1993) 1235-1239.
33. [33] Rydel, K.E. and Green, L.A., cAMP analogs promote the survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor, Proc. Natl. Acad. Sci. USA, 85 (1988) 1257-1261.
34. [34] Shewey, L.M. and Dorsa, D.M., V1-type vasopressin receptors in rat brain septum: binding characteristics and effects on inositol phospholipid metabolism, J. Neurosci., 8 (1988) 1671-1677.
35. [35] Shivers, B.D., Gorcs, T.J., Gottschall, P.E. and Arimura, A., Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions, Endocrinology, 128 (1991) 3055-3065.
36. [36] Sklair-Tavron, L. and Segal, M., Neurotrophic effects of cAMP generating systems on central noradrenergic neurons, Brain Res., 614 (1993) 257-269.
37. [37] Snider, W.D., Functions of the neurotrophins during nervous system development: what the knockouts are teaching us, Cell, 77 (1994) 627-638.
38. [38] Sofroniew, M. V., Projection from vasopressin, oxytocin, and neurophysin neurons to neural targets in the rat and human, J. Histochem. Cytochem., 28 (1980) 475-478.
39. [39] Spengler, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburg, P.H. and Journot, L., Differential signal transduction by 5 splice variants of the PACAP receptor, Nature, 365 (1993) 170-175.
40. [40] Tatsuno, I. and Arimura, A., Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates intracellular free calcium concentration on rat cultured astrocytes in type-2, but not in type-1, Brain Res., 662 (1994) 1-10.
41. [41] Tatsuno, I., Gottschall, P.E. and Arimura, A., Specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat cultured astrocytes: molecular identification and interaction with vasoactive intestinal peptide (VIP), Peptides, 12 (1991) 617-621.
42. [42] Tatsuno, I., Gottschall, P.E., Koves, K. and Arimura, A., Demonstration of specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat astrocytes, Biochem. Biophys. Res. Commun., 168 (1990) 1027-1033.
43. [43] Tatsuno, I., Somogyvari-Vigh, A., Mizuno, K., Gottschall, P.E., Hidaka, H. and Arimura, A., Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide, Endocrinology, 129 (1991) 1797-1804.
44. [44] Tatsuno, I., Sonogyvari-Vigh, A. and Arimura, A., Developmental changes of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor in the rat brain, Peptides, 15 (1994) 55-60.
45. [45] Tatsuno, I., Yada, T., Vigh, S., Hidaka, H. and Arimura, A., Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons, Endocrinology, 131 (1992) 73-81.
46. [46] Uchida, D., Shjoda, S., Takai, A. and Arimura, A., Cytoprotective action of pituitary adenylate cyclase activating polypeptide (PACAP) in ischemia-induced neuronal cell death in rat hippocampus, 24th Ann. Meeting Soc. Neurosci. Abstr., 20 (1994) No. 193.10, p. 442.
47. [47] Ueda, S., Minamino, N., Aburaya, M., Kangawa, K., Matsukura, S. and Matsuo, H., Distribution and characterization of immunoreactive porcine C-type natriuretic peptide, Biochem. Biophys. Res. Commun., 175 (1991) 759-767.